Clinical trial
Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin…
NCT00244855 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00244855 |
|---|---|
| Title | Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma |
| Official title | Rituximab and Dexamethasone in CD20 Positive Low Grade and Follicular Non-Hodgkin's Lymphoma |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Recurrent Grade 1 Follicular Lymphoma and 13 more |
| Intervention type | Biological, Drug, Other |
| Interventions | pharmacological study, rituximab, dexamethasone, laboratory biomarker analysis |
| Enrollment | 32 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Aug 29, 2011 |
| First posted | Oct 27, 2005 |
| Last update posted | May 22, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: